Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Subcutaneous Hydrocortisone Infusion in CAH
NCT01771328Phase 2Unknown
- Sponsor
- Haukeland University Hospital
- Start
- Feb 2013
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydrocortisone in congenital adrenal hyperplasia (CAH), sponsored by Haukeland University Hospital. Status: unknown.
02
Drugs
hydrocortisone
03
Conditions
congenital adrenal hyperplasia (CAH)
Beyond the preview
Go deeper on NCT01771328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01771328.